Use of precision cut human liver slices for studying the metabolism and genotoxic potential of xenobiotics by means of the ³²P-postlabelling technique: steps towards method validation using testosterone and 2-aminofluorene

Reference

• BACH, P. H., VICKERS, A. E. M., FISHER, R., BAUMANN, A., BRITTEBO, E., CARLILE, D.1, KOSTER, H. J., LAKE, B. G., SALMON, E, SAWYER, T. W. and SKIBINKSI, G. 1996, The use of tissue slices for pharmacotoxicology studies. AT LA — Alternative to Laboratory Animals, 24, 893–923.
   Google Scholar
• BADAWI, A. E, HIRVONEN, A., BELL, D. A., LANG, N. P. and KADLUBAR, E E 1995, Role of aromatic amine acetyltransferases, NATI and NAT2, in carcinogen—DNA adduct formation in the human urinary bladder. Cancer Research, 55,5230–5237.
   Google Scholar
• BAUMANN, A., KERDAR, R. S., CRAMER, P., FESER, W., BLODE, H., SALOMON, A. and KUHNZ, W. 1996, Use of rat and human liver slices for the detection of steroid hormone-induced DNA-adducts in vitro by means of the 32P-postlabeling technique. Pharmacology and Toxicology, 78, 214–223.
   PubMedGoogle Scholar
• BEAMOND, J. A., PRICE, R. J., BLOWERS, S. D., WIELD, P. T., CUNNINGHAME, M. E. and LAKE, B. G. 1994, Use of precision-cut liver slices for studies of unscheduled DNA-synthesis. Food and Chemical Toxicology, 32, 819–829.
   PubMed Web of Science ®Google Scholar
• BELAND, E A. and KADLUBAR, E E 1990, Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In Chemical Carcino genesis and Mutagenesis, C. S. Cooper and P.L. Grover, eds (Berlin: Springer-Verlag), pp. 267–325.
   Google Scholar
• BLAAUBOER, B. J., BOOBIS, A. R., CASTELL, J. V., COECKE, S., GROOTHUIS, G. M. M., GUILLOUZO, A., HALL, T. J., HAWKSWORTH, G. M., LORENZON, G., MILTENBURGER, H. G., ROGIERS, V., S K ET T, P., VILLA, P. and WIEBEL, E J. 1994, The practical applicability of hepatocyte cultures in routine testing. A TLA — Alternatives to Laboratory Animal 4 22, 231–241.
   Google Scholar
• BRENDEL, K., GANDOLFI, A. J., KRUMDIECK, C. L. and SMITH, P. E 1987, Tissue slicing and culturing revisited. Trends in Pharmacological Sciences, 8,11–15.
   Web of Science ®Google Scholar
• BUTLER, M. A., IWASAKI, M., GUENGERICH, E P. and KADLUBAR, E E 1989, Human cytochrome P-450pA (P-450IA2), the phenacetin 0-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N- oxidation of carcinogenic arylamines. Proceedings of the N ational Academy of Sciences; USA, 86, 7696–7700.
   Google Scholar
• BUTTERWORTH, B. E., SMITH-OLIVER, T., EARLE, L., LOURRY, D. J., WHITE, R. D., DOOLITTLE, D. J., WORKING, P. K., CATTLEY, R. C., JIRTLE, R., MICHALOPOLOS, G. and STROM, S. 1989, Use of primary cultures of human hepatocytes in toxicology studies. Cancer Research, 49, 1075–1084.
   Google Scholar
• CONNERS, S., RANKIN, D. R., GANDOLFI, J., KRUMDIECK, C. L., KOEP, L. J. and BRENDEL, K. 1990, Cocain hepatotoxicity in cultured liver slices: a species comparison. Toxicology, 61,171–183.
   PubMed Web of Science ®Google Scholar
• CULP, S. J., POIRIER, M. C. and BELAND, E A. 1993, Biphasic removal of DNA-adducts in a repetitive DNA sequence after dietary administration of 2-acetylaminofluorene. Environmental Health Perspectives, 99, 273–275.
   PubMed Web of Science ®Google Scholar
• DOGTEROM, P. 1993, Development of a simple incubation system for metabolism studies with precision-cut liver slices. Drug Metabolism and Disposition, 21, 699–704.
   PubMed Web of Science ®Google Scholar
• DRAHUSHUK, A. T., MCGARRIGLE, B. P., TAI, H. L., KITIREEWAN, S., GOLDSTEIN, J. A. and OLSON, J. A. 1996, Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP 1A1 and CYP1A2 induction. Toxicology and Applied Pharmacology, 140, 393–403.
   PubMed Web of Science ®Google Scholar
• ENGELHARDT, D., EISENBURGH, J., UNTERBURGER, P. and KARL, H. J. 1971, Untersuchungen über den Stoffwechsel von Testosteron und 44-Anrostendion in der Leber des Menschen. Klinische Wochenschrift, 49, 439–440.
   PubMedGoogle Scholar
• ENGELHARDT, D., UNTERBURGER, P. and KARL, H. J. 1974, Studies on testosterone metabolism in liver and extrahepatic tissues of man. Journal of Steroid Biochemistry, 5, 318–319.
   Google Scholar
• FENG, YI, JIANG, W. and HEIN, D. W. 1996,2-aminofluorene — DNA adduct levels in tumor-target and nontarget organs of rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus. Toxicology and Applied Pharmacology, 141, 248–255.
   PubMed Web of Science ®Google Scholar
• FESER, W., KERDAR, R. S., BAUMANN, A., KöRBER, J., BLODE, H. and KuHNz, W. 1998, DNA adduct formation of selected sex steroids in human liver slices in vitro. Toxicology in vitro, 12, 353–364.
   Google Scholar
• FISHER, R. L., BRENDEL, K. and HANZLIK, R. P. 1993, Correlation of metabolism, covalent binding and toxicity for a series of brombenzene derivatives using rat liver slices in vitro. Chemico-Biological Interactions, 88, 191–208.
   PubMed Web of Science ®Google Scholar
• FISHER, R. L., HASAL, S. J., SIPES, I. G., GANDOLFI, A. J. and BRENDEL, K. 1995, Comparative metabolism and toxicity of dichlorobenzenes in Sprague—Dawley, Fischer-344 and human liver slices. Human and Experimental Toxicology, 14, 414–421.
   PubMed Web of Science ®Google Scholar
• GALLAGHER, J. E., JACKSON, M. A., GEORGE, M. H., LEWTAS, J. and ROBERTSON, I. G. C. 1989, Differences in detection of DNA adducts in the 32P-postlabeling assay after either L-butanol extraction or nuclease P1 treatment. Cancer Letters, 45, 7–12.
   PubMed Web of Science ®Google Scholar
• GUILLOUZO, A. 1992, Hepatotoxicity. In In vitro Toxicity Testing. Applications to Safety Evaluation, J. M. Frazier, ed. (New York, Marcel Dekker), pp. 45-83.
   Google Scholar
• GUILLOUZO, A., MOREL, E, FARDEL, O. and MEUNIER, B. 1993, Use of human hepatocyte cultures for drug metabolism studies. Toxicology, 82, 209–219.
   PubMed Web of Science ®Google Scholar
• GUPTA, R. C., REDDY, M. V. and RANDERATH, K. 1982,32P-postlabeling analysis of nonradioactive aromatic carcinogen—DNA adducts. Carcino genesis, 3, 1081–1092.
   PubMed Web of Science ®Google Scholar
• GUPTA, R. C. 1985, Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen DNA adducts. Cancer Research, 45, 5656–5662.
   PubMed Web of Science ®Google Scholar
• GUPTA, R. C. and EARLEY, K. 1988,32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcino genesis, 9, 1687–1693.
   Google Scholar
• GUPTA, R. C. and SPENCE-BEACH, G. 1996, Natural and endogenous adducts as detected by 32P - postlabeling. Regulatory Toxicology and Pharmacology, 23, 14–21.
   Google Scholar
• KIRLIN, W. G., TRINIDAD, A., YEROKUN, T., OGOLLA, E, FERGUSON, R. J., ANDREWS, A. E, BRADY, P. K. and HEIN D. W. 1989, Polymorphic expression of acetyl coenzyme A-dependent 0-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosols. Cancer Research, 49, 2448–2454.
   Google Scholar
• KOCHAKIAN, C. D. 1990, Metabolites of testosterone: significance in the vital economy. Steroids, 55, 92–97.
   PubMedGoogle Scholar
• KRUMDIECK, C. L., DOS SANTOS, J. E. and Ho, K. J. 1980, A new instrument for the rapid preparation of tissue slices. Analytical Biochemistry, 104, 118–123.
   PubMed Web of Science ®Google Scholar
• LAKE, B. G., BEAMOND, J. A., WIELD, P. T. and PRICE, R.J. 1996, Use of precision-cut liver slices to evaluate species differences in 2-acetylaminofluorene-induced unscheduled DNA-synthesis. Toxicology and Applied Pharmacology, 138, 231–241.
   PubMed Web of Science ®Google Scholar
• LISBOA, B. P., DRosst, J. and BREUER, H. 1965, Stoffwechsel vonTestosteron in Leberschnitten des Menschen. Zeitschrift ft& Physikalische Chemie, 342, 123–131.
   Google Scholar
• MIIENPAA, J., PELKONEN, O., CRESTEIL, T. and RANE, A. 1993, The role of cytochrome P450 3A (CYP3A) isoform(s) in the oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. Journal of Steroid Biochemistry and Molecular Biology, 44, 61–67.
   PubMed Web of Science ®Google Scholar
• MASER, E. 1995, Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. Biochemical Pharmacology, 49, 421–440.
   PubMed Web of Science ®Google Scholar
• MILLER, J. A. and MILLER, E. C. 1966, Mechanisms of chemical carcinogenesis: Naturate of proximate carcinogens and interactions with macromolecules. Pharmacological Review, 18, 805–838.
   PubMed Web of Science ®Google Scholar
• MILLER, E. C. and MILLER, J. A. 1981, Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer, 47,2327–2345.
   PubMed Web of Science ®Google Scholar
• MILLER, G., BEYER, J., HALL, G. L., DE GRAFFENRIED, L. A. and ADAMS, P. E. 1993, Predictive value of liver slices for metabolism and toxicity in vivo: use of acetaminophen as a model hepatotoxicant. Toxicology and Applied Pharmacology, 104, 108–116.
   Google Scholar
• MONTHEITH, D. K. and GUPTA, R. C. 1992, Carcinogen—DNA-adducts in cultures of rat and human hepatocytes. Cancer Letters, 62, 87–93.
   PubMed Web of Science ®Google Scholar
• OGURI, K., YAMADA, H. and YOSHIMURA, H. 1994, Regiochemistry of cytochrome P 450 isoenzyme. Annual Review of Pharmacology and Toxicology, 34, 251–279.
   PubMed Web of Science ®Google Scholar
• PHILLIPS, D., CASTEGNARO, M. and BARTSC HH. 1993. Postlabeling methods for detection of DNA adducts. Vol. 124 (Lyon: IARC).
   Google Scholar
• PIERCE, J. and SUELTER, C. H. 1977, An evaluation of the coomassie brilliant blue G-250 dye-binding method for quantitative protein determination. Analytical Biochemistry, 81, 478–480.
   PubMed Web of Science ®Google Scholar
• PURCHASE, I. E H. 1994, Current knowledge of mechanisms of carcinogenicity: Genotoxicity versus non-genotoxins. Human and Experimental Toxicology, 13,17–28.
   PubMed Web of Science ®Google Scholar
• RANDERATH, K. and RANDERATH, E. 1994, 32P-postlabeling methods for DNA adduct detection: Overview and critical evaluation. Drug Metabolism Reviews, 26, 67–85.
   PubMed Web of Science ®Google Scholar
• REDDY, M. V. and RANDERATH, K. 1986, Nuclease P1-mediated enhancement of sensitivity of 32P - postlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543–1551.
   PubMed Web of Science ®Google Scholar
• SIPES, I. G., FISHER, R. L., SMITH, P. E, STINE, E. R., GANDOLFI, A. J. and BRENDEL, K. 1987, A dynamic liver culture system: a tool for studying chemical biotransformation and toxicity. A rchives of Toxicology, Suppl. 11,20–33.
   PubMed Web of Science ®Google Scholar
• SMITH, P. E, FISHER, R., SHUBAT, P. J., GANDOLFI, A. J., KRUMDIECK, C. L., KOEP, L. J. and BRENDEL, K. 1987, In vitro cytotoxicity of ally' alcohol and bromobenzene in a novel organ culture system. Toxicology and Applied Pharmacology, 87,509–522.
   PubMed Web of Science ®Google Scholar
• SMITH, P. E, GANDOLFI, A. J., KRUMDIECK, C. L., PUTNAM, C. W., ZUKOSKI, C. E, DAVIS, W. M. and BRENDEL, K. 1985, Dynamic organ culture of precision liver slices for in vitro toxicology. Life Sciences, 36,1367–1375.
   PubMed Web of Science ®Google Scholar
• SMITH, P. E, McKEE, R., GANDOLFI, P. A. J., KRUMDIECK, C. L., FISHER, R. and BRENDEL, K. 1989, Precision-cut liver slices: a new in vitro in toxicology. In In vitro Toxicology: Model Systems and Methods, C.A. McQueen, ed. (New Jersey: Telford Press), pp. 93–130.
   Google Scholar
• STYLIANOU, M., FORCHIELLI, E., TummLo, M. and DORFMAN, R. I. 1961, Metabolism in vitro of 4-C14-testosterone by a human liver homogenate. Journal of Biological Chemistry, 236, 692–694.
   Web of Science ®Google Scholar
• SWIERENGA, S. H. H., BRADLAW, J. A., BRILLINGER, R. L., GILMAN, J. P. W., NESTMANN, E. R. and SAN, R. C. 1991, Recommended protocols based on survey of current practice in genotoxicity testing laboratories. I. Unscheduled DNA synthesis assay in rat hepatocyte culures. Mutations Research, 246, 235–253.
   Google Scholar
• TOPINKA, J., ANDRAE, U., SCHWARZ, L. R. and WOLFF, T. 1993, Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures. C arcino genesis, 14, 423-427 WAXMAN, D. J. 1988, Interaction of hepatic cytochromes P450 with steroid hormones. Biochemical Pharmacology, 37, 48–71.
   Google Scholar
• WAXMAN, D. J., LAPENSON, D. P., AOYAMA, T., GELBOIN, H. V., GONZALES, E J. and KORZEKWA, K. 1991, Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Archives of Biochemistry and Biophysics, 290,160–166.
   PubMed Web of Science ®Google Scholar
• WERNER, S., TOPINKA, J., KUNZ, S., BECKERTS, T., HEIDECKE, C.-D., SCHWARZ, L. R. and WOLFF, T. 1996, Studies on the formation of hepatic DNA-adducts by the antiandrogenic and gestagenic drug, cyproterone acetate. In Biological Reactive Intermediates V (New York and London: Plenum Press), pp. 253–257.
   Google Scholar
• WILLIAMS, G. M. 1977), Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cultures. Cancer Research, 37,1854–1851.
   Web of Science ®Google Scholar
• WOOD, A. W., RYAN, D. E., THOMAS, P. E. and LEVIN, W. 1983, Regio- and stereoselective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P450 isozym es. Journal of Biological Chemistry, 258, 8839–8847.
   PubMed Web of Science ®Google Scholar
• WORTMANN, W., KNAPSTEIN, P., MAPPES, G., DICK, G. and OERTEL, G. W. 1971, /n vivo perfusion of the human liver with steroids. Acta Endocrinologica, 68,561–566.
   PubMedGoogle Scholar